Clinical webinar explores testing for Graves’ Disease
Learn about clinical aspects of Graves’ Disease and the use of TSH immunoglobulin assay for diagnosis and monitoring
17 Jun 2024
Graves' Disease is an immune disorder affecting the thyroid gland. ©123rf.com.
Every month, our editors select one clinical webinar to highlight to our community of clinical laboratory scientists, biomedical scientists, medical laboratory professionals and other healthcare professionals.
This month, our highlighted webinar is:
Thyroid-stimulating immunoglobulin assay for Graves’ Disease detection
Graves’ disease (GD) is caused by circulating autoantibodies that stimulate the TSH receptor (TSHR), leading to unregulated production and secretion of thyroid hormones. Measurement of TSHR antibodies (TRAb) in patient serum is a sensitive tool to assess GD. In addition to diagnosis, there are several other clinical implications where TRAb measurement is valuable. Functionally, TRAb can be divided into two main categories – thyroid-stimulating antibodies (TSAb, TSI) and thyroid-blocking antibodies (TBAb, TBI) – that can (co)exist in patients with GD.
In this webinar, there is discussion around:
- Clinical and pathophysiological aspects of GD, including Graves’ orbitopathy
- TRAb nomenclature
- Different types of TRAb bindings and functional assays
- Clinical application of the TSI assay
Key learning objectives
- Explain the clinical and pathophysiological aspects of Graves’ disease, including Graves’ orbitopathy
- Determine the different types of TRAb bindings and functional assays
- Discuss the clinical application of the TSI assay
Who should watch this on-demand webinar?
- Clinicians/Doctors
- Laboratorians/Biomedical scientists
- Specialists
- Government decision makers
- Healthcare professionals
Accreditation statement
SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes. SelectScience clinical webinars can be added to HCPC and IBMS portfolios as evidence of CPD. For each webinar, attendees can download a certificate of attendance to add to their portfolios. Each webinar has a list of key learning objectives that can be used to help with reflective practice.